• Search
  • Advanced Search

Cirrhosis and portal hypertension

  • HOME
  • TOPICS
  • Cirrhosis and portal hypertension
Topics
Snapshot
1662
Acute on chronic liver failure in cirrhosis
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2022;28(2):273-275.   Published online February 14, 2022
Letter to the Editor
Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Jihyun An, Ju Hyun Shim
Clin Mol Hepatol. 2022;28(2):267-268.   Published online January 18, 2022
Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Yi-Chun Huang, Chih-Wei Chen, James Chun-Chung Wei
Clin Mol Hepatol. 2022;28(2):265-266.   Published online January 4, 2022
Original Article
1655
Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats
Ki Tae Yoon, Hongqun Liu, Jing Zhang, Sojung Han, Samuel S. Lee
Clin Mol Hepatol. 2022;28(2):232-241.   Published online January 5, 2022
1623
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song
Clin Mol Hepatol. 2022;28(2):219-231.   Published online July 20, 2021
Editorial
1628
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
Takumi Kawaguchi, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):177-180.   Published online August 26, 2021
Review
1636
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
Hae Lim Lee, Sung Won Lee
Clin Mol Hepatol. 2022;28(2):121-134.   Published online September 27, 2021
Original Article
1642
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2022;28(1):77-90.   Published online November 5, 2021
1638
Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim
Clin Mol Hepatol. 2022;28(1):67-76.   Published online October 12, 2021
Review
1626
Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clin Mol Hepatol. 2022;28(1):31-46.   Published online August 2, 2021
1617
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
Ho Soo Chun, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Clin Mol Hepatol. 2021;27(4):535-552.   Published online June 16, 2021
1600
Changes in the epidemiology and management of bacterial infections in cirrhosis
Salvatore Piano, Marta Tonon, Paolo Angeli
Clin Mol Hepatol. 2021;27(3):437-445.   Published online January 28, 2021
1611
β-blockers in advanced cirrhosis: More friend than enemy
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
Clin Mol Hepatol. 2021;27(3):425-436.   Published online December 3, 2020
1578
Anti-fibrotic treatments for chronic liver diseases: The present and the future
Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada
Clin Mol Hepatol. 2021;27(3):413-424.   Published online December 3, 2020
Original Article
1582
Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study
Suk-Yong Jang, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee, Hyuk Soo Eun
Clin Mol Hepatol. 2021;27(2):283-294.   Published online December 3, 2020
Editorial
A need for patient-centered care in managing patients with liver cirrhosis
Eileen L. Yoon
Clin Mol Hepatol. 2021;27(2):270-272.   Published online January 27, 2021
Original Article
1595
The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
Se Ri Ryu, Jeong-Ju Yoo, Seong Hee Kang, Soung Won Jeong, Moon Young Kim, Young Kyu Cho, Young Chang, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Soon Koo Baik, Yong Jae Kim, Su Yeon Park, Baigal Baymbajav
Clin Mol Hepatol. 2021;27(1):197-206.   Published online December 3, 2020
1572
Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients
Priyanka Jain, Saggere Muralikrishna Shasthry, Ashok Kumar Choudhury, Rakhi Maiwall, Guresh Kumar, Ankit Bharadwaj, Vinod Arora, Rajan Vijayaraghavan, Ankur Jindal, Manoj Kumar Sharma, Vikram Bhatia, Shiv Kumar Sarin
Clin Mol Hepatol. 2021;27(1):175-185.   Published online December 3, 2020
Editorial
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2021;27(1):94-96.   Published online December 3, 2020
The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?
Beom Kyung Kim
Clin Mol Hepatol. 2021;27(1):91-93.   Published online December 3, 2020
Review
1579
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
Clin Mol Hepatol. 2021;27(1):70-80.   Published online December 3, 2020
1547
Managing liver cirrhotic complications: Overview of esophageal and gastric varices
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
Clin Mol Hepatol. 2020;26(4):444-460.   Published online October 1, 2020
1510
Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis
Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada
Clin Mol Hepatol. 2020;26(3):280-293.   Published online June 4, 2020
Letter to the Editor
Multimodal sequential treatment for occluded TIPS: Case report and review of literature
Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele
Clin Mol Hepatol. 2020;26(2):227-230.   Published online November 18, 2019
Guideline
1494
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Clin Mol Hepatol. 2020;26(2):83-127.   Published online January 10, 2020
Letter to the Editor
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms
Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol. 2020;26(1):78-82.   Published online November 26, 2019
Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
Zhang Cheng, Feng Wang, Jianfei Liu
Clin Mol Hepatol. 2019;25(4):417-419.   Published online June 19, 2019
Original Article
Incidence and risk factors of dysphagia after variceal band ligation
Saraswathi Arasu, Hammad Liaquat, Jaspreet Suri, Adam C. Ehrlich, Frank K. Friedenberg
Clin Mol Hepatol. 2019;25(4):374-380.   Published online July 18, 2019
Review
1459
Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Ankur Jindal, Rakesh Kumar Jagdish
Clin Mol Hepatol. 2019;25(3):270-279.   Published online April 22, 2019
Original Article
Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt
Dongmei Zhao, Guobing Zhang, Mingquan Wang, Chaoxue Zhang, Jiabin Li
Clin Mol Hepatol. 2019;25(2):210-217.   Published online March 22, 2019

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 590
TOTAL : 912581
Close layer